0001209191-21-046030.txt : 20210708
0001209191-21-046030.hdr.sgml : 20210708
20210708181732
ACCESSION NUMBER: 0001209191-21-046030
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210706
FILED AS OF DATE: 20210708
DATE AS OF CHANGE: 20210708
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Stalfort John A III
CENTRAL INDEX KEY: 0001709418
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40551
FILM NUMBER: 211081208
MAIL ADDRESS:
STREET 1: C/O ACUMEN PHARMACEUTICALS, INC.
STREET 2: 427 PARK STREET
CITY: CHARLOTTESVILLE
STATE: VA
ZIP: 22902
FORMER NAME:
FORMER CONFORMED NAME: Stalfort Sean
DATE OF NAME CHANGE: 20170615
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Acumen Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001576885
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 364108129
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4435 NORTH FIRST STREET, SUITE 360
CITY: LIVERMORE
STATE: CA
ZIP: 94551
BUSINESS PHONE: 925-368-8508
MAIL ADDRESS:
STREET 1: 4435 NORTH FIRST STREET, SUITE 360
CITY: LIVERMORE
STATE: CA
ZIP: 94551
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-07-06
0
0001576885
Acumen Pharmaceuticals, Inc.
ABOS
0001709418
Stalfort John A III
C/O ACUMEN PHARMACEUTICALS, INC.
427 PARK STREET
CHARLOTTESVILLE
VA
22902
1
0
0
0
Common Stock
2021-07-06
4
C
0
130180
A
137324
D
Common Stock
2021-07-06
4
P
0
35000
16.00
A
172324
D
Common Stock
2021-07-06
4
C
0
131595
A
131595
I
See footnote
Series A-1 Preferred
2021-07-06
4
C
0
130180
0.00
D
Common Stock
130180
0
D
Series B Preferred
2021-07-06
4
C
0
131595
0.00
D
Common Stock
131595
0
I
See footnote
On July 6, 2021, each share of Series A-1 Convertible Preferred Stock and each share of Series B Convertible Preferred Stock converted into Common Stock on a one-for-one basis without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date.
The securities are held by Gineane Holly Stalfort, as Trustee of the John A. Stalfort III 2018 Irrevocable Trust under agreement dated as of
October 25, 2018.
/s/ Katherine Denby, Attorney-in-Fact
2021-07-08